The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation***Post-Survey, Evaluation, & Credit Claim***

In order to receive credit for this activity, you must read the front matter, view the activity, complete the post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements.

There is no fee to participate in this activity.

Question Title

* 1. Where are you in your career?

IBD Specialist

General GI

GI Surgeon

Fellow/Trainee

APP

PharmD

Other (please specify)

Question Title

* 2. What is your community of practice?

Academic

Community

Industry

Other (please specify)

Question Title

* 3. Which section of the intestines demonstrates the greatest intestinal adaptation following bowel loss?

Duodenum

Ileum

Jejunum

Large intestine

Question Title

* 4. Which of the following is a potential complication of prolonged administration of parenteral nutrition?

Interstitial lung disease

Metabolic bone disease

Thrombocytopenia

Urolithiasis

Question Title

* 5. At this point, if reported by the patient, which of the following is most likely to represent an adverse effect of teduglutide?

Abdominal pain

Headache

Insomnia

Tremor

Question Title

* 6. How long after initiation of teduglutide should patients undergo a colonoscopy?

3 months

6 months

9 months

12 months

Question Title

* 7. A 9-year-old patient with SBS has been unable to wean from PN and had 3 admissions for CVL infections over the past year. Their stool output is 60mL/kg. Which of the following is the best next option for this patient to reduce PN dependence?

Cyproheptadine

Loperamide

Somatropin

Teduglutide

Question Title

* 8. A 13-year-old patient with short bowel syndrome was started on teduglutide 6 months ago due to inability to wean from parenteral nutrition (PN). They have since been able to decrease their PN volume by 50% and report no significant adverse events. Which of the following studies is indicated for this patient at this time?

Colonoscopy

C-reactive protein (CRP)

Lipase

Upper GI series

Question Title

* 9. Approximately how many patients with SBS do you currently see each week?

1-3

4-6

7-9

10+

I do not directly provide care for patients with SBS

Question Title

* 10. Upon completion of this activity, I am able to:

	Strongly agree	Agree	Disagree	Strongly disagree
Select pharmacologic options for treatment of patients with SBS	Select pharmacologic options for treatment of patients with SBS Strongly agree	Select pharmacologic options for treatment of patients with SBS Agree	Select pharmacologic options for treatment of patients with SBS Disagree	Select pharmacologic options for treatment of patients with SBS Strongly disagree

Question Title

* 11. Please indicate the extent of your agreement with the following statements:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
The faculty were effective in presenting the material	The faculty were effective in presenting the material Strongly agree	The faculty were effective in presenting the material Agree	The faculty were effective in presenting the material Neutral	The faculty were effective in presenting the material Disagree	The faculty were effective in presenting the material Strongly disagree
Information in this activity is relevant to my clinical practice	Information in this activity is relevant to my clinical practice Strongly agree	Information in this activity is relevant to my clinical practice Agree	Information in this activity is relevant to my clinical practice Neutral	Information in this activity is relevant to my clinical practice Disagree	Information in this activity is relevant to my clinical practice Strongly disagree
The activity increased my knowledge on this topic	The activity increased my knowledge on this topic Strongly agree	The activity increased my knowledge on this topic Agree	The activity increased my knowledge on this topic Neutral	The activity increased my knowledge on this topic Disagree	The activity increased my knowledge on this topic Strongly disagree
The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.)	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Strongly agree	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Agree	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Neutral	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Disagree	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Strongly disagree
The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity)	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Strongly agree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Agree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Neutral	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Disagree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Strongly disagree

Question Title

* 12. Please rate your level of agreement by selecting the appropriate rating:
The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Was fair, balanced, objective, and free of commercial bias	Was fair, balanced, objective, and free of commercial bias Strongly agree	Was fair, balanced, objective, and free of commercial bias Agree	Was fair, balanced, objective, and free of commercial bias Neutral	Was fair, balanced, objective, and free of commercial bias Disagree	Was fair, balanced, objective, and free of commercial bias Strongly disagree

Question Title

* 13. Based upon your participation in this activity, do you intend to change your practice behavior?

I plan to implement changes in my practice based on the information presented

My current practice has been reinforced by the information presented

I need more information before I will change my practice

Not applicable to my scope of practice

Question Title

* 14. How confident are you that you will be able to make your intended changes?

Very confident

Somewhat confident

Unsure

Not confident

Question Title

* 15. Which of the following do you anticipate will be the primary barrier to implementing these changes? (check all that apply):

Formulary restrictions

Time constraints

System constraints

Patient adherence/compliance

Insurance/financial issues

Lack of interprofessional team support

Treatment related adverse events

None

Other (please specify)

Question Title

* 16. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 17. For purposes of certification, please complete the following information. Please note that we will not forward or sell your contact information.

First Name *

Last Name *

Degree/Credentials:

City

State/Province

ZIP/Postal Code *

Country

Email Address (required to receive credit) *

Question Title

* 18. I certify that I have participated in the continuing education activity entitled, "The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation" and claim 1.0 AMA PRA Category 1 Credit^TM.

Yes

Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4-6 weeks to receive your certificate.

For information about the certification of this program, please contact Partners for Advancing Clinical Education (PACE) at contactus@partnersed.com.

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation***Post-Survey, Evaluation, & Credit Claim***

Question Title

* 1. Where are you in your career?

Question Title

* 2. What is your community of practice?

Question Title

* 3. Which section of the intestines demonstrates the greatest intestinal adaptation following bowel loss?

Question Title

* 4. Which of the following is a potential complication of prolonged administration of parenteral nutrition?

Question Title

* 5. At this point, if reported by the patient, which of the following is most likely to represent an adverse effect of teduglutide?​

Question Title

* 6. How long after initiation of teduglutide should patients undergo a colonoscopy?

Question Title

* 7. A 9-year-old patient with SBS has been unable to wean from PN and had 3 admissions for CVL infections over the past year. Their stool output is 60mL/kg. Which of the following is the best next option for this patient to reduce PN dependence?

Question Title

Question Title

* 9. Approximately how many patients with SBS do you currently see each week?

Question Title

* 10. Upon completion of this activity, I am able to:

Question Title

* 11. Please indicate the extent of your agreement with the following statements:

Question Title

* 12. Please rate your level of agreement by selecting the appropriate rating:The content presented:

Question Title

* 13. Based upon your participation in this activity, do you intend to change your practice behavior?

Question Title

* 14. How confident are you that you will be able to make your intended changes?

Question Title

* 15. Which of the following do you anticipate will be the primary barrier to implementing these changes? (check all that apply):

Question Title

* 16. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 17. For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*

Question Title

* 18. I certify that I have participated in the continuing education activity entitled, "The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation" and claim 1.0 AMA PRA Category 1 CreditTM.

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation
Post-Survey, Evaluation, & Credit Claim

* 5. At this point, if reported by the patient, which of the following is most likely to represent an adverse effect of teduglutide?

* 12. Please rate your level of agreement by selecting the appropriate rating:
The content presented:

* 17. For purposes of certification, please complete the following information. Please note that we will not forward or sell your contact information.

* 18. I certify that I have participated in the continuing education activity entitled, "The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome ~ Patient Case Simulation" and claim 1.0 AMA PRA Category 1 Credit^TM.